Velphoro (sucroferric oxyhydroxide)

pCPA File Number: 21089
Negotiation Status:
Concluded with an LOI
Indication(s):
Hyperphosphatemia, end-stage renal disease
Sponsor/Manufacturer:
Vifor Fresenius Medical Care Renal Pharma
CADTH Project Number:
SR0571-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: